Journey Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Journey Medical Corp
DERM Stock  USD 5.55  0.19  3.31%   
Journey Medical financial statements provide useful quarterly and yearly information to potential Journey Medical Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Journey Medical financial statements helps investors assess Journey Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Journey Medical's valuation are summarized below:
Gross Profit
42.9 M
Profit Margin
(0.32)
Market Capitalization
115.9 M
Enterprise Value Revenue
1.9611
Revenue
57.8 M
There are over one hundred nineteen available fundamental trends for Journey Medical Corp, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to confirm Journey Medical's regular fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 28th of November 2024, Market Cap is likely to grow to about 120.6 M. Also, Enterprise Value is likely to grow to about 105.4 M

Journey Medical Total Revenue

41.75 Million

Check Journey Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Journey Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4 M, Interest Expense of 1.6 M or Selling General Administrative of 53.8 M, as well as many indicators such as Price To Sales Ratio of 1.26, Dividend Yield of 0.0 or PTB Ratio of 3.5. Journey financial statements analysis is a perfect complement when working with Journey Medical Valuation or Volatility modules.
  
Check out the analysis of Journey Medical Correlation against competitors.

Journey Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets73 M76.8 M184.6 M
Slightly volatile
Short and Long Term Debt Total16.8 M17.7 M82.1 M
Very volatile
Total Current Liabilities46.9 M41.9 M34.7 M
Slightly volatile
Property Plant And Equipment Net96 K101 K388.3 K
Very volatile
Accounts Payable15.5 M18.1 M11.9 M
Slightly volatile
Cash26.1 M27.4 M65 M
Pretty Stable
Non Current Assets Total16.4 M20.4 M34.2 M
Slightly volatile
Non Currrent Assets Other5.7 K6 K726.4 K
Slightly volatile
Cash And Short Term Investments26.1 M27.4 M130.9 M
Pretty Stable
Net Receivables17.6 M15.2 M14.1 M
Slightly volatile
Good Will616.8 K693.9 K755.6 K
Slightly volatile
Common Stock Shares Outstanding18.8 M18.2 M18.6 M
Slightly volatile
Short Term Investments181 M239.3 M149.5 M
Slightly volatile
Liabilities And Stockholders Equity73 M76.8 M184.6 M
Slightly volatile
Non Current Liabilities Total13.9 M14.6 M53.5 M
Very volatile
Other Current Assets3.4 M3.6 M3.3 M
Slightly volatile
Other Stockholder Equity88.1 M92.7 M195.3 M
Very volatile
Total Liabilities93.1 M56.5 M90.3 M
Pretty Stable
Total Current Assets53.6 M56.5 M150.2 M
Pretty Stable
Short Term Debt2.6 M3.1 M1.8 M
Slightly volatile
Intangible Assets21.3 M20.3 M8.4 M
Slightly volatile
Common Stock1.7 K1.8 K19 K
Slightly volatile
Inventory8.2 M10.2 M8 M
Very volatile
Other Assets81.2 K85.5 K874.8 K
Slightly volatile
Long Term Debt12.3 M14.6 M8.3 M
Slightly volatile
Capital Lease Obligations145.6 K108 K103.6 K
Slightly volatile
Net Invested Capital31 M35 M16.3 M
Slightly volatile
Property Plant And Equipment Gross145.2 K101 K110.7 K
Slightly volatile
Capital Stock1.8 K2.3 K1.3 K
Slightly volatile
Non Current Liabilities Other1.2 M1.3 M4.4 M
Slightly volatile
Net Working Capital15.4 M14.6 M8.3 M
Slightly volatile
Property Plant Equipment149.1 K217.3 K114 K
Slightly volatile
Other Liabilities6.8 K7.2 K74.6 K
Slightly volatile
Short and Long Term Debt2.1 M3.4 M1.2 M
Slightly volatile

Journey Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization4 M3.9 M1.3 M
Slightly volatile
Interest Expense1.6 M1.7 M2.6 M
Pretty Stable
Selling General Administrative53.8 M48.1 M38.4 M
Slightly volatile
Total Revenue41.7 M79.2 M30 M
Slightly volatile
Gross Profit29 M52.5 M21.5 M
Slightly volatile
Other Operating Expenses91 M81.3 M92.3 M
Pretty Stable
Total Operating Expenses81.8 M54.6 M84 M
Pretty Stable
Cost Of Revenue21.2 M26.7 M9.8 M
Slightly volatile
Tax Provision102.6 K108 K1.2 M
Slightly volatile
Reconciled Depreciation2.5 M4.3 M979.2 K
Slightly volatile

Journey Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2.5 M2.6 M5.8 M
Very volatile
Begin Period Cash Flow49.5 M32 M50.4 M
Very volatile
Depreciation4 M3.9 M1.3 M
Slightly volatile
Capital Expenditures4.5 M5 M3 M
Slightly volatile
End Period Cash Flow26.1 M27.4 M57.6 M
Very volatile
Change To Operating Activities664.3 K699.3 K8.3 M
Slightly volatile
Change To Netincome26.5 M25.3 M6.9 M
Slightly volatile
Dividends Paid317.2 K333.9 K1.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.261.326313.1588
Pretty Stable
Days Sales Outstanding66.6670.1687219
Slightly volatile
Stock Based Compensation To Revenue0.03130.03290.7883
Very volatile
Capex To Depreciation1.231.2972.7439
Slightly volatile
EV To Sales1.141.20379.6243
Very volatile
Inventory Turnover2.482.61222.2978
Slightly volatile
Days Of Inventory On Hand1331401.6 K
Slightly volatile
Payables Turnover1.41.4691.2152
Slightly volatile
Sales General And Administrative To Revenue3.973.673.5526
Slightly volatile
Research And Ddevelopement To Revenue0.09050.09523.9925
Slightly volatile
Capex To Revenue0.05980.06310.0595
Slightly volatile
Cash Per Share1.431.5058.0442
Slightly volatile
Days Payables Outstanding2362483.1 K
Slightly volatile
Intangibles To Total Assets0.280.2640.1055
Slightly volatile
Current Ratio1.281.34845.5153
Slightly volatile
Receivables Turnover4.945.20178.0866
Very volatile
Graham Number2.192.303723.75
Slightly volatile
Capex Per Share0.180.27420.1708
Slightly volatile
Revenue Per Share4.564.34291.9518
Slightly volatile
Interest Debt Per Share1.011.05971.5159
Pretty Stable
Debt To Assets0.190.22930.1756
Slightly volatile
Operating Cycle1992101.7 K
Slightly volatile
Days Of Payables Outstanding2362483.1 K
Slightly volatile
Ebt Per Ebit0.911.75211.0876
Slightly volatile
Long Term Debt To Capitalization0.530.41810.3824
Slightly volatile
Total Debt To Capitalization0.330.46410.2968
Slightly volatile
Quick Ratio1.051.10465.4363
Slightly volatile
Net Income Per E B T0.751.06080.9539
Slightly volatile
Cash Ratio0.620.65542.4917
Slightly volatile
Days Of Inventory Outstanding1331401.6 K
Slightly volatile
Days Of Sales Outstanding66.6670.1687219
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.04350.04581.2465
Pretty Stable
Fixed Asset Turnover823784241
Slightly volatile
Debt Ratio0.190.22930.1756
Slightly volatile
Price Sales Ratio1.261.326313.1588
Pretty Stable
Asset Turnover1.081.03030.386
Slightly volatile
Gross Profit Margin0.750.66330.8405
Slightly volatile

Journey Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap120.6 M105 M139.6 M
Slightly volatile
Enterprise Value105.4 M95.3 M134.2 M
Slightly volatile

Journey Fundamental Market Drivers

Forward Price Earnings111.1111
Cash And Short Term Investments27.4 M

Journey Upcoming Events

3rd of April 2024
Upcoming Quarterly Report
View
27th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Journey Medical Financial Statements

Journey Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Journey Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-2.3 M-2.1 M
Total Revenue79.2 M41.7 M
Cost Of Revenue26.7 M21.2 M
Stock Based Compensation To Revenue 0.03  0.03 
Sales General And Administrative To Revenue 3.67  3.97 
Research And Ddevelopement To Revenue 0.10  0.09 
Capex To Revenue 0.06  0.06 
Revenue Per Share 4.34  4.56 
Ebit Per Revenue(0.03)(0.03)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:
How To Invest In Journey
Details
Is Journey Stock a good investment?
Details
What is Journey Medical's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Journey Medical Correlation against competitors.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.92)
Revenue Per Share
2.921
Quarterly Revenue Growth
(0.58)
Return On Assets
(0.17)
Return On Equity
(1.30)
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY